Supriya Lifescience Limited (BOM:543434)

Supriya Lifescience Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	788.67	760.57	683.49	852.51	1,658
Short-Term Investments	-	-	30.97	66.07	723.31	591.55
Cash & Short-Term Investments	788.67	788.67	791.54	749.56	1,576	2,249
Cash Growth	-0.36%	-0.36%	5.60%	-52.43%	-29.94%	160.26%
Accounts Receivable	-	2,194	1,344	1,117	846.64	1,152
Other Receivables	-	-	7.1	45.09	64.06	60.32
Receivables	-	2,200	1,358	1,169	916.16	1,218
Inventory	-	1,596	1,183	852.49	1,158	923.12
Prepaid Expenses	-	-	102.43	112.25	108.48	72.45
Other Current Assets	-	738.22	935.04	1,097	890.71	512.77
Total Current Assets	-	5,323	4,370	3,980	4,649	4,975
Property, Plant & Equipment	-	7,234	5,995	4,573	3,281	2,317
Long-Term Investments	-	985.23	632.41	637.95	252.96	0.53
Other Intangible Assets	-	13.12	13.89	16.56	11.06	15.09
Other Long-Term Assets	-	15.81	111.55	6.8	9.28	39.82
Total Assets	-	13,571	11,123	9,214	8,203	7,348

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	1,108	745.46	595.69	642.28	489.72
Accrued Expenses	-	-	30.27	29.61	27.58	29.58
Short-Term Debt	-	-	-	-	166.25	212.95
Current Portion of Leases	-	2.46	3.23	4.68	3.54	8.25
Current Income Taxes Payable	-	-	-50.33	-24.68	45.87	64.11
Other Current Liabilities	-	99.51	92.99	165.76	72.28	192.38
Total Current Liabilities	-	1,210	821.62	771.06	957.8	996.99
Long-Term Leases	-	51.89	50.57	50.2	54.89	52.95
Pension & Post-Retirement Benefits	-	-	-	-	47.3	26.73
Long-Term Deferred Tax Liabilities	-	312.44	270.18	231.52	136.75	111.49
Other Long-Term Liabilities	-	18.97	13.17	8.03	11.45	2.59
Total Liabilities	-	1,594	1,156	1,061	1,208	1,191

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	160.97	160.97	160.97	160.97	160.97
Additional Paid-In Capital	-	-	1,985	1,985	1,985	1,985
Retained Earnings	-	-	7,820	6,004	4,862	4,011
Comprehensive Income & Other	-	11,816	1.57	2.82	-13.42	-0.01
Shareholders' Equity	11,977	11,977	9,968	8,154	6,995	6,157
Total Liabilities & Equity	-	13,571	11,123	9,214	8,203	7,348

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	54.35	54.35	53.8	54.88	224.68	274.15
Net Cash (Debt)	734.32	734.32	737.74	694.68	1,351	1,975
Net Cash Growth	-0.46%	-0.46%	6.20%	-48.59%	-31.59%	1287.90%
Net Cash Per Share	9.13	9.12	9.17	8.63	16.79	24.54
Filing Date Shares Outstanding	80.41	80.51	80.48	80.48	80.48	80.48
Total Common Shares Outstanding	80.41	80.51	80.48	80.48	80.48	80.48
Working Capital	-	4,113	3,549	3,209	3,691	3,978
Book Value Per Share	148.77	148.77	123.85	101.31	86.91	76.50
Tangible Book Value	11,964	11,964	9,954	8,137	6,984	6,142
Tangible Book Value Per Share	148.61	148.61	123.67	101.10	86.77	76.31
Land	-	-	109.23	104.16	91.64	91.6
Buildings	-	-	1,291	857.69	724.16	546.76
Machinery	-	-	3,810	2,621	2,132	1,474
Construction In Progress	-	-	1,480	1,488	676.28	434.09

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error